, Tracking Stock Market Picks
Enter Symbol:
AcelRx Pharmaceuticals Inc (ACRX) [hlAlert]

up 25.65 %

AcelRx Pharmaceuticals Inc (ACRX) upgraded to Buy with price target $10.50 by ROTH Capital

Posted on: Monday,  Oct 5, 2015  8:25 AM ET by Roth Capital

Roth Capital rated Buy AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) on 10/05/2015, when the stock price was $3.43. Since
then, AcelRx Pharmaceuticals Inc has gained 25.66% as of 01/06/2016's recent price of $4.31.
If you would have followed this Roth Capital's recommendation on ACRX, you would have gained 25.65% of your investment in 93 days.

AcelRx Pharmaceuticals, Inc. is a development-stage company. The Company is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of acute and breakthrough pain. It has completed Phase 2 clinical development for two additional product candidates, the Sufentanil NanoTab BTP Management System, or ARX-02, for the treatment of cancer breakthrough pain (BTP), and the Sufentanil/Triazolam NanoTab, or ARX-03, designed to provide mild sedation, anxiety reduction and pain relief for patients undergoing painful procedures in a physician?s office. The Company is preparing to initiate two Phase 3 clinical trials for its product candidate, the Sufentanil NanoTab PCA System, or ARX-01. ARX-02 is a product candidate for the treatment of cancer patients who suffer from breakthrough pain. ARX-03 Sufentanil/Triazolam NanoTab is a single, fixed-dose sublingual product candidate.

ROTH researches emerging growth equities in the media, technology, telecommunications, healthcare, consumer, energy and industrial sectors. The research is focused on companies with market capitalization of between $100 million - $1 billion. Our coverage universe includes approximately 180 small cap growth companies around the globe including several companies from China. With an average market cap of approximately $500 million, our objective is to identify rapidly growing companies with significant long term growth prospects.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/5/2015 8:25 AM Buy
3.43 10.50
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/26/2014 1:25 PM Hold

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy